The definition of storage period is a key link in ensuring quality and safety in material management work. However, many practitioners are often confused by the difference in the expression of "expiration date" and "retest period" on material labels - although both refer to storage time, their connotations and application scenarios are very different. This article will systematically analyze the core differences, scope of application, and key points of application between the two, in order to assist practitioners in scientifically managing materials and avoiding quality risks.

1、 First understanding the 'validity period': the legally defined quality and safety boundary

Validity period "refers to the period during which a drug or material continuously meets the standard requirements in terms of quality under specified storage conditions. This deadline is not subjectively set, but based on rigorous stability test data: researchers simulate different storage environments such as temperature, humidity, and light, monitor key indicators such as composition, purity, and performance of materials for a long time, and ultimately determine the duration for which they can maintain qualified quality.

From the perspective of attributes, the validity period has clear legal enforceability. According to relevant regulations, once materials exceed their expiration date, regardless of whether there are significant changes in appearance, they must be scrapped according to law and cannot be put back into use. The core purpose of this regulation is to eliminate quality hazards caused by expired materials from the source - whether in pharmaceutical production or other industrial applications, the use of expired materials may lead to substandard product performance and even threaten human health and production safety.

In practical scenarios, expiration dates are commonly found in formulations (such as tablets, injections, and other finished drugs) and raw materials with poor stability (such as biological products and antibiotic materials). This type of material is prone to degradation and loss of activity due to its components. It is necessary to define a safe usage boundary through a clear expiration date to ensure that the quality of each batch of material is controllable throughout its entire lifecycle.

2、 Looking at the're inspection period 'again: a quality assurance tool for dynamic management

Unlike the expiration date, the "re inspection period" refers to materials such as raw materials, packaging materials, etc. After a certain period of storage, in order to confirm that they can still meet the intended use requirements, the enterprise independently determines the re inspection node. For example, setting a retest period of 12 months for a batch of pharmaceutical packaging materials means that when the batch of materials is stored for 12 months, an inspection procedure needs to be initiated to verify whether its physical properties and chemical stability meet production requirements.

The basis for establishing the retest period is more diverse, in addition to stability test data, it also needs to be combined with long-term material usage experience. Its core feature is that "materials that have exceeded the retest period can continue to be used": materials that have exceeded the retest period are not directly eliminated, but their quality status is judged through re inspection - if they pass the inspection, they can continue to be stored or put into use; If it is not qualified, it shall be disposed of according to regulations. This dynamic management mode makes the re inspection period a tool for scientifically extending the material usage cycle, but it must strictly follow standardized procedures.

Negative warning: A pharmaceutical company has sparked controversy over intermediate management. When the intermediate produced under its commission was nearing expiration, although the company believed that the quality was stable through accelerated testing and extended the use period on its own, it did not strictly follow the management standards for the retest period - it did not fully comply with the necessary approvals required by regulations, and there was a contradiction between the time statement and actual operation, ultimately resulting in the suspension of the marketing authorization of 1300 kilograms of intermediate produced drugs by regulatory authorities. This case illustrates that the application of the retest period must be based on compliant inspection processes and data support, and cannot be operated arbitrarily.

3、 How to choose? Anchoring regulatory requirements and material characteristics

In the selection of "validity period" and "re inspection period", it is necessary to combine international general rules and domestic regulatory requirements, while matching the material's own characteristics:

From the perspective of internationally recognized standards, formulations and raw materials with poor stability (such as vaccines and cephalosporin antibiotics) are susceptible to environmental impact due to their quality, and therefore, expiration date management should be prioritized, as shown in the case of cefoperazone sodium and sulbactam sodium raw materials mentioned above; Raw materials, pharmaceutical excipients, and packaging materials with strong stability are more suitable for dynamic control during the retest period due to slow quality changes after long-term storage, and ensure applicability through regular inspections.

Domestic regulations also have a clear definition of this: according to the requirements of the Drug Administration Law, the labels of formulations and active pharmaceutical ingredients must indicate the "expiration date", and there is no applicable space for the "retest period"; Pharmaceutical excipients and packaging materials can be flexibly selected - companies can set expiration dates or retest periods, but regardless of the method chosen, they must go through market related review to ensure the scientificity and compliance of the deadline setting. The case of Shenghe Pharmaceutical indirectly confirms this point: even for intermediates that can be managed with a retest period, their period adjustment and use must comply with regulatory requirements such as GMP.

4、 Practical points of the re inspection period: full process control from formulation to application

For materials selected for retest period management, it is important to focus on the following practical steps to ensure that the management process is standardized and effective:

1. Establishment of the first CI retest period: dual support of data and experience

The setting of the first CI retest period should be based on sufficient evidence and cannot be subjectively inferred. Enterprises need to combine stability test data (such as accelerated tests and long-term test results), refer to technical information provided by material manufacturers, and incorporate the practical experience of management personnel and actual storage conditions of materials (such as warehouse temperature and humidity control levels, packaging sealing). It is generally recommended in the industry that the first CI retest period should not exceed 3 years, and subsequent adjustments can be gradually optimized based on long-term monitoring data. As in the above case, although a pharmaceutical company conducted accelerated trials, the extension of the deadline still sparked controversy due to the lack of complete stability data accumulation and compliance approval processes. This lesson is worth learning from.

2. Adjustment of retest interval: based on data as the core basis

The retest interval is not fixed and needs to be dynamically adjusted based on the stability of material quality. If there is a lack of sufficient stability data support, after the first CI retest period, sampling inspection must be conducted before each use of materials to ensure that the quality is qualified; If the stability of the material is confirmed to be good through long-term monitoring and the results of multiple consecutive retests meet the standards, the interval can be appropriately extended (such as from 6 months to 12 months) on the premise of data support, but the rationality of the adjustment needs to be regularly reviewed.

3. Judgment of the number of retests: comprehensive multi factor decision-making

In theory, as long as the results of each retest are qualified, the material can be retested and reused multiple times. However, in practical operation, a comprehensive judgment needs to be made based on three factors: first, the characteristics of the material itself (such as the possibility of aging of some polymer materials after long-term storage, and the number of retests needs to be strictly limited); The second is the stability monitoring results (if it is found that the quality indicators are showing a downward trend, the number of retests should be reduced or the use should be terminated in advance); The third is the actual production demand (such as when the frequency of material usage is low and inventory backlog is severe, it is necessary to increase the frequency of retesting appropriately to avoid risks caused by long-term storage). This process can refer to the relevant recommendations in the appendix of the "Drug GMP Guidelines" to ensure scientific and compliant decision-making.

Conclusion

As the two core tools of material storage management, "expiration date" and "retest period" respectively carry the functions of "legal safety boundary" and "dynamic quality assurance". In practical work, practitioners need to accurately grasp the differences and applicable scenarios between the two, choose appropriate management methods based on regulatory requirements and material characteristics, and standardize the entire process operation of the re inspection period. Only in this way can we achieve efficient utilization of resources and promote the development of material management towards a more scientific and compliant direction, while ensuring the quality and safety of materials.